Go Pro

NewAmsterdam Pharma (NAMS) Institutional Ownership

NewAmsterdam Pharma logo
$27.79 0.00 (0.00%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$27.76 -0.04 (-0.13%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for NewAmsterdam Pharma (NASDAQ:NAMS)

Current
Institutional Ownership
Percentage
89.89%
Number of
Institutional Buyers
(last 12 months)
112
Total
Institutional Inflows
(last 12 months)
$539.73M
Number of
Institutional Sellers
(last 12 months)
54
Total
Institutional Outflows
(last 12 months)
$596.95M
Get NAMS Insider Trade Alerts

Want to know when executives and insiders are buying or selling NewAmsterdam Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

NAMS Institutional Buying and Selling by Quarter

NewAmsterdam Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/10/2026 Handelsbanken Fonder AB122,400$4.15M0.0%-70.8%0.105%
5/26/2026Glenmede Trust Co. NA18,575$595K0.0%-16.4%0.016%
5/19/2026Bank of America Corp DE847,089$27.12M0.0%+84.4%0.725%
5/19/2026Stempoint Capital LP180,658$5.78M1.1%+147.1%0.155%
5/19/2026Janus Henderson Group PLC2,258,984$72.25M0.0%-3.5%1.932%
5/18/2026California State Teachers Retirement System54,329$1.74M0.0%+34.9%0.046%
5/18/2026Royal Bank of Canada11,314$362K0.0%-53.0%0.010%
5/18/2026Eversept Partners LP285,764$9.15M0.5%-32.1%0.244%
5/16/2026The Manufacturers Life Insurance Company 11,302$362K0.0%-50.2%0.010%
5/16/2026Maverick Capital Ltd.2,186,402$69.99M0.8%+15.4%1.902%
5/14/2026Sei Investments Co.55,637$1.78M0.0%+35.6%0.048%
5/14/2026Walleye Capital LLC58,434$1.87M0.0%-39.3%0.051%
5/13/2026 Mizuho Markets Cayman LP52,227$1.67M0.1%+9.1%0.045%
5/13/2026Decheng Capital LLC325,057$10.41M1.6%-45.1%0.283%
5/13/2026First Trust Advisors LP267,105$8.55M0.0%-4.5%0.232%
5/8/2026PNC Financial Services Group Inc.9,119$292K0.0%+147.7%0.008%
5/7/2026 AlphaCentric Advisors LLC14,656$469K0.5%+6.7%0.013%
5/7/2026KBC Group NV1,171$37K0.0%N/A0.001%
5/7/2026SEB Asset Management AB272,654$8.73M0.0%N/A0.237%
5/6/2026Jennison Associates LLC2,750,403$88.04M0.1%-21.2%2.392%
5/5/2026Bank of New York Mellon Corp378,800$12.13M0.0%-3.3%0.329%
4/29/2026 Swedbank AB100,900$3.23M0.0%+11.0%0.088%
4/25/2026 Keybank National Association OH12,480$399K0.0%-4.7%0.011%
4/24/2026 Peregrine Capital Management LLC178,493$5.71M0.2%N/A0.155%
4/22/2026 Pictet Asset Management Holding SA6,533$209K0.0%-99.1%0.006%
4/22/2026Medicxi Ventures Management Jersey Ltd2,674,182$85.60M8.7%-6.8%2.326%
4/17/2026 AdvisorNet Financial Inc2,565$82K0.0%N/A0.002%
2/26/2026Seven Fleet Capital Management LP4,000$140K0.1%N/A0.004%
2/19/2026Invesco Ltd.5,961$209K0.0%-94.3%0.005%
2/18/2026Empowered Funds LLC2,428$85K0.0%N/A0.002%
2/18/2026XTX Topco Ltd137,492$4.82M0.1%+1,714.1%0.121%
2/18/2026Ikarian Capital LLC45,830$1.61M0.1%-57.1%0.040%
2/18/2026Virtus Investment Advisers LLC7,142$251K0.1%+32.0%0.006%
2/18/2026Twinbeech Capital LP27,400$961K0.1%N/A0.024%
2/18/2026Millennium Management LLC254,596$8.93M0.0%N/A0.225%
2/18/2026Ishara Investments LP30,000$1.05M1.2%N/A0.026%
2/18/2026Janus Henderson Group PLC2,341,723$82.30M0.0%+10.6%2.065%
2/18/2026Eversept Partners LP420,827$14.76M0.7%-13.9%0.371%
2/18/2026Castle Hook Partners LP1,085,008$38.06M0.2%N/A0.957%
2/18/2026Cormorant Asset Management LP1,000,000$35.08M1.6%-54.0%0.882%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
2/18/2026Artia Global Partners LP503,936$17.68M2.4%+158.6%0.444%
2/18/2026Boothbay Fund Management LLC33,919$1.19M0.0%-16.7%0.030%
2/17/2026Guggenheim Capital LLC6,388$224K0.0%N/A0.006%
2/17/2026Logos Global Management LP450,000$15.79M1.0%N/A0.397%
2/17/2026Viking Global Investors LP4,203,567$147.46M0.4%-35.1%3.707%
2/17/2026ADAR1 Capital Management LLC118,623$4.16M0.3%+3.7%0.105%
2/17/2026Jain Global LLC47,584$1.67M0.0%N/A0.042%
2/17/2026RA Capital Management L.P.9,550,191$335.02M3.4%-5.8%8.422%
2/17/2026Bain Capital Life Sciences Investors LLC7,306,566$256.31M19.6%-31.8%6.444%
2/17/2026ArrowMark Colorado Holdings LLC298,077$10.46M0.2%-4.2%0.263%
2/17/2026Price T Rowe Associates Inc. MD116,258$4.08M0.0%-16.0%0.103%
2/17/2026Adage Capital Partners GP L.L.C.1,406,631$49.35M0.1%-45.4%1.241%
2/17/2026California State Teachers Retirement System40,276$1.41M0.0%-15.8%0.036%
2/17/2026Russell Investments Group Ltd.71,282$2.50M0.0%N/A0.063%
2/17/2026Fcpm Iii Services B.V.9,198,900$322.70M42.8%-0.1%8.113%
2/17/2026State of Wisconsin Investment Board19,997$701K0.0%N/A0.018%
2/17/2026Fred Alger Management LLC47,535$1.67M0.0%+15.2%0.042%
2/17/2026Royal Bank of Canada24,084$846K0.0%-9.1%0.021%
2/17/2026Persistent Asset Partners Ltd3,948$138K0.1%N/A0.003%
2/17/2026Polar Capital Holdings Plc2,776,222$97.39M0.4%-4.7%2.448%
2/16/2026Squarepoint Ops LLC30,819$1.08M0.0%+47.0%0.027%
2/16/2026Verition Fund Management LLC32,391$1.14M0.0%+134.2%0.029%
2/16/2026PEAK6 LLC20,749$728K0.0%N/A0.018%
2/16/2026Nicholas Investment Partners LP213,419$7.49M0.5%+20.2%0.188%
2/16/2026First Turn Management LLC893,473$31.34M3.6%+24.6%0.788%
2/16/2026Frazier Life Sciences Management L.P.16,943,774$594.39M16.0%+1.4%14.943%
2/16/2026Kennedy Capital Management LLC172,931$6.07M0.1%+17.9%0.153%
2/13/2026Maverick Capital Ltd.1,894,226$66.45M0.7%+25.9%1.671%
2/13/2026Walleye Capital LLC96,261$3.38M0.0%N/A0.085%
2/13/2026Quarry LP3,000$105K0.0%-56.4%0.003%
2/13/2026First Trust Advisors LP279,701$9.81M0.0%N/A0.247%
2/13/2026State Street Corp68,523$2.40M0.0%+7.4%0.060%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC265,199$9.30M0.0%N/A0.234%
2/13/2026Wells Fargo & Company MN900$32K0.0%+50.0%0.001%
2/13/2026Lord Abbett & CO. LLC200,638$7.04M0.0%N/A0.177%
2/12/2026Orion Porfolio Solutions LLC6,545$230K0.0%N/A0.006%
2/12/2026Decheng Capital LLC592,057$20.77M2.8%-9.9%0.522%
2/12/2026Ensign Peak Advisors Inc549,511$19.28M0.0%N/A0.485%
2/12/2026 AlphaCentric Advisors LLC13,731$482K0.5%N/A0.012%
2/12/2026CIBC Private Wealth Group LLC7,240$254K0.0%-5.2%0.006%
2/12/2026 Alps Advisors Inc.92,902$3.26M0.0%N/A0.082%
2/12/2026Swiss National Bank88,900$3.12M0.0%+2.1%0.078%
2/12/2026Polen Capital Management LLC11,239$394K0.0%N/A0.010%
2/11/2026Empowered Funds LLC2,428$85K0.0%N/A0.002%
2/11/2026DCF Advisers LLC160,600$5.63M1.5%-8.4%0.142%
2/11/2026Deutsche Bank AG123,963$4.35M0.0%+81.2%0.109%
2/11/2026Fox Run Management L.L.C.9,798$344K0.1%N/A0.009%
2/11/2026Franklin Resources Inc.769,120$26.98M0.0%+89.5%0.678%
2/11/2026CenterBook Partners LP12,060$423K0.0%-82.9%0.011%
2/11/2026JPMorgan Chase & Co.999,976$35.08M0.0%-23.2%0.882%
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
2/11/2026Capital World Investors9,984,000$350.24M0.0%+1.6%8.805%
2/11/2026WINTON GROUP Ltd28,665$1.01M0.0%N/A0.025%
2/10/2026TD Asset Management Inc13,180$462K0.0%-26.8%0.012%
2/10/2026Goldman Sachs Group Inc.1,725,662$60.54M0.0%+96.0%1.522%
2/10/2026JTC Employer Solutions Trustee Ltd75,500$2.65M0.2%N/A0.067%
2/10/2026 SBI Okasan Asset Management Co.Ltd.14,900$522K0.0%N/A0.013%
2/9/2026Geode Capital Management LLC102,395$3.59M0.0%+0.4%0.090%
2/9/2026Knights of Columbus Asset Advisors LLC32,483$1.14M0.1%-3.4%0.029%
2/9/2026 Swedbank AB90,900$3.19M0.0%N/A0.080%
2/9/2026Lisanti Capital Growth LLC179,410$6.29M1.5%+278.1%0.158%


NAMS Institutional Ownership - Frequently Asked Questions

During the previous two years, 186 institutional investors and hedge funds held shares of NewAmsterdam Pharma. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($594.39M), Capital World Investors ($350.24M), RA Capital Management L.P. ($335.02M), Fcpm Iii Services B.V. ($322.70M), Bain Capital Life Sciences Investors LLC ($256.31M), Viking Global Investors LP ($147.46M), and Deerfield Management Company L.P. ($121.35M).Learn more on NewAmsterdam Pharma's institutional investors.

89.89% of NewAmsterdam Pharma's stock is owned by institutional investors. Learn more on NAMS's institutional investor holdings.

Of the 163 institutional investors that purchased NewAmsterdam Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wellington Management Group LLP ($6.38M), Frazier Life Sciences Management L.P. ($4.62M), Jennison Associates LLC ($4.31M), Deerfield Management Company L.P. Series C ($3.61M), Capital World Investors ($2.61M), Alliancebernstein L.P. ($2.33M), and RA Capital Management L.P. ($2.07M).

Institutional investors have bought a total of 18,536,596 shares in the last 24 months. This purchase volume represents approximately $539.73M in transactions.

Of the 54 institutional investors that sold NewAmsterdam Pharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Bain Capital Life Sciences Investors LLC ($3.41M), Viking Global Investors LP ($2.77M), Jennison Associates LLC ($1.45M), Fcpm Iii Services B.V. ($1.43M), Pictet Asset Management Holding SA ($1.29M), Cormorant Asset Management LP ($1.18M), and Adage Capital Partners GP L.L.C. ($1.17M).

Institutional investors have sold a total of 18,259,065 shares in the last 24 months. This volume of shares sold represents approximately $596.95M in transactions.



This page (NASDAQ:NAMS) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners